The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course
If youve been struggling with weight loss, blood sugar swings, or stubborn A1C numbers, youre not aloneand youre not broken
Were talking about a diabetes and obesity drug
Acts on the pituitary gland to regulate the secretion of reproductive hormone
The components work synergistically - methionine, inositol and choline may help with fat metabolism while B12 can support energy production and potentially reduce fatigue
Patients should retain all purchase confirmation documentation